Evidence map›Paper›PMID 39367511›Full record

ArticleCell communication and signaling : CCS2024

STAT3 blockade ameliorates LPS-induced kidney injury through macrophage-driven inflammation.

Song-Hee Lee, Kyu Hong Kim, Seong Min Lee, Seong Joon Park, Sunhwa Lee, Ran-Hui Cha, Jae Wook Lee, Dong Ki Kim, Yon Su Kim, Sang-Kyu Ye and 1 more

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Therapeutic potential of targeting macrophage polarization in metastatic gastric cancer: a review on core mechanisms and clinical progress.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  14. Article
  15. Article
  16. Review
  17. Augmenting the Endogenous RBM3 Response Protects Against Burn-Induced Acute Kidney Injury by Enhancing Macrophage-Mediated Resolution of Inflammation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Song-Hee Lee *Department of Biomedical Sciences, Seoul National University, Seoul, Republic of Korea.
Kyu Hong Kim *Department of Biomedical Sciences, Seoul National University, Seoul, Republic of Korea.
Seong Min Lee *Department of Biomedical Sciences, Seoul National University, Seoul, Republic of Korea.
Seong Joon ParkDepartment of Biomedical Sciences, Seoul National University, Seoul, Republic of Korea.
Sunhwa LeeDepartment of Internal Medicine, Division of Nephrology, Kangwon National University Hospital, Chuncheon, Gangwon-Do, Republic of Korea.
Ran-Hui ChaBiomedical Research Institute, Seoul National University Hospital, Hospital, Seoul, Republic of Korea.
Jae Wook LeeNephrology Clinic, National Cancer Center of Korea, Seoul, Republic of Korea.
Dong Ki KimDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Yon Su KimDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Sang-Kyu YeDepartment of Biomedical Sciences, Seoul National University, Seoul, Republic of Korea. sangkyu@snu.ac.kr.
Seung Hee YangDepartment of Kidney Research Institute, Seoul National University Medical Research Center, Seoul, Republic of Korea. ysh5794@snu.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSignal transducer and activator of transcription 3 (STAT3), a multifaceted transcription factor, modulates host immune responses by activating cellular response to signaling ligands. STAT3 has a pivotal role in the pathophysiology of kidney injury by counterbalancing resident macrophage phenotypes under inflammation conditions. However, STAT3's role in acute kidney injury (AKI), particularly in macrophage migration, and in chronic kidney disease (CKD) through fibrosis development, remains unclear.

methodsStattic (a JAK2/STAT3 inhibitor, 5 mg/kg or 10 mg/kg) was administered to evaluate the therapeutic effect on LPS-induced AKI (L-AKI) and LPS-induced CKD (L-CKD), with animals sacrificed 6-24 h and 14 days post-LPS induction, respectively. The immune mechanisms of STAT3 blockade were determined by comparing the macrophage phenotypes and correlated with renal function parameters. Also, the transcriptomic analysis was used to confirm the anti-inflammatory effect of L-AKI, and the anti-fibrotic role was further evaluated in the L-CKD model.

resultsIn the L-AKI model, sequential increases in BUN and blood creatinine levels were time-dependent, with a marked elevation of 0-6 h after LPS injection. Notably, two newly identified macrophage subpopulations (CD11b

conclusionsSTAT3 blockade effectively mitigated inflammation by retrieving the CD11b

Indexed as

Acute Kidney InjuryInflammationLipopolysaccharidesMacrophagesSTAT3 Transcription FactorAnimalsCyclic S-OxidesDisease Models, AnimalFibrosisMaleMiceMice, Inbred C57BLSignal TransductionCyclic S-OxidesLipopolysaccharidesStat3 protein, mouseSTAT3 Transcription FactorstatticAKIFibrosisLPSMacrophage-driven inflammationSTAT3

Identifiers

PMID39367511
PMCPMC11453053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.